would like to see US ADR or similar listing sooner rather than later. Am guessing that a wider pool of potential US investors are only going to get motivated once they can buy easily on a US marketplace through their trusted US based broker, perhaps aided by some US research from a well regarded US house.
Ann: Cynata Engages CRO to Conduct GvHD Clinical Trial, page-8
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.0¢ | $22.07K | 99.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16557 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 2454 | 2 |
View Market Depth
| Last trade - 15.59pm 06/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |